10035-aha-2020-sessions
10381-dse-conference-planning-and-campaign
10685-global-brand-portal-announcement
9094-ats-booth-driver
9401-onboarding-welcome-email
9833-ers-email-driver
9838-ats-email-driver
9838-ats-youtube-email-driver
9841-market-development-positioning-research
escitalopram-0012-hcp-crm-email-1
escitalopram-0012-hcp-crm-email-2
escitalopram-0012-hcp-crm-email-3
escitalopram-0012-hcp-crm-email-4
escitalopram-0012-hcp-crm-email-5
escitalopram-0024-hcp-follow-up-rte
escitalopram-0025-hcp-welcome-rte
escitalopram-0028-hcp-alert-marketing-email-1
escitalopram-0028-hcp-alert-marketing-email-2
escitalopram-0042-hcp-alert-marketing-email-2
escitalopram-0043-hcp-alert-marketing-email-1
10808-avion-unmet-needs-emails
11119-dhivy-now-available-hcp-email
11192-avion-now-available-rep-triggered-emails
11348-DHIVY-DMD-Now-Available-Email
11416-dmd-branded-email
11428-DHIVY-AAN-Rep-Emails
11505-avion-pd-awareness-month-email
11631-hcp-rep-triggered-email
11696-dmd-branded-email-2
10071-na-promo-efficacy-safety-thyroid
10467-na-efficacy-safety-veeva-email-combined
10500-na-dosing-veeva-combined
10501-na-resources-veeva-combined
10543-hcp-efficacy-veeva-email-combined
10545-hcp-unbranded-wait-for-test-results-veeva-email
10606-gavreto-new-data-veeva-email
10688-sampling-program-veeva-email
10689-nccn-veeva-email
10900-lcam-veeva-email
11228-gavreto-hcp-ons-email-booth-driver
11414-gavreto-hcp-asco-2022-veeva-email
11603-gavreto-2022-tcam-veeva-email
11642-gavreto-patient-offerings-veeva-email
11742-2022-lcam-veeva-email
11770-gavreto-hcp-unbranded-tc-about-ret-veeva-email
11829-gavreto-unbranded-nsclc-biomarker-testing-veeva-email
12062-gavreto-patient-julie-video-veeva-email
12150-gavreto-nsclc-tc-resources-veeva-email
12490-gavreto-2023-splash-campaign-veeva-email
12602-gavreto-medtrix-driver-nsclc-veeva-email
12807-gavreto-dosing-and-administration-veeva-email
12808-gavreto-follow-up-visit-veeva-email
12809-gavreto-hcp-sampling-program-veeva-email
12810-gavreto-nccn-guidelines-veeva-email
12824-hcp-tc-efficacy-safety-veeva-email
12891-gavreto-nsclc-full-approval-veeva-email
12892-gavreto-patient-resources-and-materials-veeva-email
12893-gavreto-thyroid-cancer-patient-story-video-veeva-email
9334-blueprint-market-development-emails
9600-na-announcement-email-from-hq-combined
9636-na-yourblueprint-email-from-hq-combined
9637-na-resources-email-from-hq
9643-na-veeva-combined
9706-na-dosing-veeva-combined
9707-na-efficacy-safety-veeva-email-combined
9708-na-resources-veeva-combined
9709-market-development-veeva-email
9723-na-dtp-registration-lung
9724-na-hcp-registration
9725-na-hcp-promo-nccn
9726-combined-na-hcp-promo-nccn
9735-na-efficacy-safety-hq-email-combined
9753-na-veeva-nsclc
9754-na-promo-nsclc
9755-na-veeva-pricing-transparency
9806-na-gpo-combined
9807-na-gpo-ion-combined
9808-na-gavreto-mckesson
8492-inspire-email-campaign
10344-mm-m-email-template
haven-for-kids
haven-for-kids-2019
holiday-card-2017
holiday-card-2018
holiday-card-2019
holiday-card-2020
holiday-card-2021
holiday-card-2022
holiday-card-2023
holiday-card-2024
industry-recognition
judy-ceo
press-release
11358-rethink-fabry-comprehensive-rte
11591-alpha-mann-rte
11735-alpha-mann-genetic-testing-rte
11781-lamzede-dear-doctor-payer-rte
11785-lamzede-branded-rte
11988-chiesi-total-care-elfabrio-rte
12008-lamzede-resources-rte
12099-lamzede-now-approved-rte
12361-elfabrio-hcp-rep-intro-rte
12362-elfabrio-hcp-launch-rte
12467-elfabrio-dear-doctor-letter-rte
23-chiesi-lamzede-0005-lamzede-rep-intro-rte
25-chiesi-elfabrio-0107-elfabrio-first-isnt-only
9165-fda-approved
24-crinetics-paltusotine-0014-acro-support-ty-email
24-crinetics-paltusotine-0014-acro-truth-ty-email
7903-proceed-fall-2016
7677-branded-unbranded-emails
7868-7-email-template
9973_elfabrio_rep_triggered_veeva_email
10204-wakix-dtc-iddg-email
10241-veeva-approved-email
10666-harmony-nourishment-day
10748-payer-rep-triggered-emails-disease-education
10748-payer-rep-triggered-emails-product
10452-zynyz-now-approved
10458-zynyz-pi-based
10519-zynyz-full-claim
12748-karuna-dse-email-template-initial
12750-karuna-dse-email-template-thank-you
12839-karuna-dse-chicago-event-emails
12839-karuna-dse-chicago-event-emails-reminder
12839-karuna-dse-chicago-event-emails-thanks
12935-karuna-dse-OC-event-emails
12994 Karuna Psych Congress Corporate Irvine Invite Email
12994 Karuna Psych Congress Email
12994 Karuna Psych Congress Irvine Reminder Email
12994 Karuna Psych Congress Regional Irvine Invite Email
12994 Karuna Psych Congress Reminder Email
13093-karuna-nei-invite-email
8005-dmd-wave-1
8005-dmd-wave-2
8005-dmd-wave-2-abandoned
8005-dmd-wave-2-deprecated
8094-aan-convention
8600-dmd-wave-3
9084-patient-communication-plan-email-1
9084-patient-communication-plan-email-2
9084-patient-communication-plan-email-3
9647-docfinder-outreach
7614-crm-emails
template-adher-day1template-adher-day112template-adher-day14template-adher-day21template-adher-day35template-adher-day49template-adher-day84template-adher-welcometemplate-batch1-b-adher-day49template-batch1-b-adher-welcometemplate-batch2-adher-day21template-batch2-adher-day7template-batch2-b-adher-day21template-batch2-consider-day35-sub2template-batch2-consider-day35template-batch3-adher-day105template-batch3-adher-day56template-batch3-adher-day77template-one
7709-veeva-approved-emails
7977-2-patient-webinar-emails
8048-8-product-theater-email-invite
8053-medscape-early-use-wave-2
8053-medscape-early-use-wave-4
8053-medscape-early-use-wave-5
8191-rns-invite
8191-rns-save-date
8191-rns-thank-you
8260-03-formal-hcp-launch-email
8482-copay-coming-soon
8482-copay-launch
8500-copay-patient-coming-soon
8500-copay-patient-launch
8585-2-crm-program-considering
8585-2-crm-program-taking
7577-veeva-approved-emails
0005-rigel-tavalisse-dear-doctor-letter
0007-rezlidhia-pfiq-roc-patient-support-email
0008-tavalisse-lines-of-therapy-vae
0009-tavalisse-stop-the-cycle-vae
0010-tavalisse-moa-vae
0011-tavalisse-durable-benefit-vae
0012-tavalisse-new-patient-start-dosing-vae
0013-tavalisse-sample-program-vae
0016-rezlidhia-brand summary-vae
0016-rezlidhia-poor-prognosis-vae
0016-rezlidhia-post-venetoclax-vae
0019-tavalisse-itp-awareness-month-branded-sales-vae
0020-tavalisse-itp-awareness-month-3rd-party-email
0022-rezlidhia-brand-summary-vae
0023-rezlidhia-brand-summary-crm
0024-rezlidhia-efficacy-vae
0025-rezlidhia-efficacy-crm
0026-rezlidhia-post-chemo-efficacy-vae
0027-gavreto-hcp-access-e-blast
0028-rezlidhia-combo-subgroup-analysis-vae
0029-rezlidhia-post-ven-crm
0051-rezlidhia-safety-and-dosing-vae
0052-rezlidhia-poor-prognosis-vae
0056-rezlidhia-post-chemo-efficacy-crm
0057-rezlidhia-post-ven-efficacy-vae
0058-rezlidhia-combo-subgroup-analysis-crm
0063-rezlidhia-aml-awareness-month-vae
0067-1l-efficacy-vae
0068-rigel-2l-efficacy-vae
0069-rigel-dosing-admin-vae
0070-rigel-summary-vae
0084-gavreto-pfiq-thyroid-cancer-summary-email
0085-gavreto-pfiq-thyroid-cancer-efficacy-email
0097-gavreto-nsclc-tc-brand-summary-vae
0099-gavreto-branded-sales-vae
pfiq-ae-management-email
pfiq-nsclc-1l-efficacy-email
pfiq-nsclc-2l-efficacy-email
pfiq-nsclc-dosing-admin-email
pfiq-nsclc-summary-email
pfiq-roc-patient-support-email
0000-mod-con-all-modules
0057-urgency-unmet-need-rte
0063-efficacy-multiple-types-rte
0064-drug-load-rte
0065-safety-rte
0069-modular-content-bulk
0071-efficacy-4-weeks-rte
0072-efficacy-zero-seizures-12-months-rte
0073-number-one-asm-rte
0074-moa-rte
0075-retention-data-rte
0076-dosing-rte
0077-savings-full-access-story-rte
0096-ec-email
0110-epilepsy-awareness-month-email
0113-epilepsy-awareness-month-xu-email
0138-epilepsy-connect-announcement
0149-epilepsy-connect-rte
0156-modular-content-2026
0160-patient-exposure-data-updates
12086-levulan-hcp-rte
12400-levulan-general-rte
24-sun-levulan-0057-welcome-emails
24-sun-levulan-0095-phase-2-batch-emails
25-Sun-Odomzo-Derm-0088-Spring-Screenings-Promotional-Email
25-odomzo-derm-vmd-congress-support-email
25-sun-levulan-0168-blu-u-modular-content
25-sun-levulan-0171-blu-u-you-summer-email-5
25-unloxcyt-post-launch-kol-email
25-unloxcyt-pre-launch-party-email
25-unloxcyt-pre-launch-party-email-reminder
26-sun-levulan-0219-spring-screenings-2026
8118-veeva-letters
8152-dmd-emails
8527-td300-launch
24-UCB-VMD-0060-FINTEPLA-Steering-Committee-sorry-we-missed-you
24-UCB-VMD-0060-FINTEPLA-Steering-Committee-thank-you
24-UCB-VMD-0088-AAN-2025-Acute-Seizures-ITU
24-UCB-VMD-0088-AAN-2025-Fintepla-ITU
24-UCB-VMD-0088-AAN-2025-Post-AAN
24-UCB-VMD-0088-AAN-2025-Pre-AAN
24-UCB-VMD-0101-Fintepla-Excel-Speaker-Comms-Program-2025
25-GALD-VMD-0009-REM-Management-2025
25-MT-Pharma-VMD-0010-FY25-MTPA-Support
25-UCB-VMD-0110-AAN-NCS-AND-CNS-2025-Medical-Support
25-UCB-VMD-0168-FIN-MED-AAN-26-ITU
25-tiger-aesthetics-vmd-0001-alloclae-ais-congress-support
26-UCB-VMD-0189-AAN-2026-Post-AAN
vmd-0030-fintepla-national-broadcasts-2024
10691-batch1-unmet-needs
10691-batch2-efficacy-dosing
10691-batch3-patient-experience
10691-batch4-access
11053-port-score
9234-now-approved
9234-now-available
9246-branded-email
9406-covid-email
9922-branded-email
8886-email-templates
General
frontline
dmd
dmd
dmd
dmd_testing
iqvia
Account Attendee email invitation template
iqvia
Email Functionality_July 27 2020
iqvia
OTH-EmailContent-OCE Personal-NOV2022
iqvia
OTH-EmailContent-OCE Personal-SEP2022
rigel
Medscape Third Party-Developed Email Specifications
rigel
Medscape Variable Headers and Footers
veeva
Approved Email Content Creation Guide 20R1
veeva
Approved Email Content Creation Guide 22R2